(NewsReady.com) – President Donald Trump is doing everything he can to help scientists find treatments for the coronavirus. He’s already fast-tracked a few anti-malarial drugs, which may help lessen the symptoms in some cases, for further research. Now, the president is looking at a Japanese drug to fight COVID-19.
An influenza medicine by Japan's Fujifilm Holdings group company is effective against the new coronavirus, the Chinese government said. Beijing has began recommending the drug favipiravir, developed by Fujifilm Toyama Chemical & sold under the brand name #Avigan. (Nikkei) #Covid pic.twitter.com/O7DaefGzYt
— Daily Tribune (@tribunephl) March 29, 2020
The decades-old flu drug, Avigan, is currently undergoing clinical trials in Japan. However, there are unknowns about the drug’s effectiveness and concerns about the side effects it produces. Right now, critics don’t believe there’s enough data on the drug to warrant use for treating COVID-19 cases.
Trump is working with the FDA to have it authorize Avigan with emergency-use authorization (EUA). The president’s administration is enthusiastic about the drug’s potential. While the world scrambles for a coronavirus vaccine, perhaps further research into the drug could aid in that endeavor.
~Daily News for Busy People!
Copyright 2020, NewsReady.com